TrialThe lancet. HIV2024

Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study.

Aditya H Gaur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.